Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
Background: Several studies have demonstrated the antitumor activity of rosiglitazone (RGZ) in cancer cells, includ- ing breast cancer cells. However, the molecular targets of RGZ in the inhibition of angiogenesis in breast cancer cells remain unclear. This study aimed to explore the potential tar...
Saved in:
| Main Authors: | , |
|---|---|
| 格式: | Article PeerReviewed |
| 語言: | English |
| 出版: |
Springer
2022
|
| 主題: | |
| 在線閱讀: | https://repository.ugm.ac.id/278720/1/Hermawan_FA.pdf https://repository.ugm.ac.id/278720/ https://bmcgenomdata.biomedcentral.com/articles/10.1186/s12863-022-01086-2 https://doi.org/10.1186/s12863-022-01086-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|